These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 9145003)

  • 1. In vitro antifungal activity of the new triazole D0870 against Penicillium marneffei compared with that of amphotericin B, fluconazole, itraconazole, miconazole and flucytosine.
    Boon-Long J; Mekha N; Poonwan N; Kusum M; Mikami Y; Yazawa K; Konyama K
    Mycoses; 1996; 39(11-12):453-6. PubMed ID: 9145003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro susceptibility of Trichosporon beigelii to antifungal agents.
    Perparim K; Nagai H; Hashimoto A; Goto Y; Tashiro T; Nasu M
    J Chemother; 1996 Dec; 8(6):445-8. PubMed ID: 8981185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro susceptibility of mycelial and yeast forms of Penicillium marneffei to amphotericin B, fluconazole, 5-fluorocytosine and itraconazole.
    Sekhon AS; Garg AK; Padhye AA; Hamir Z
    Eur J Epidemiol; 1993 Sep; 9(5):553-8. PubMed ID: 8307142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of broth dilution and semisolid agar dilution for in vitro susceptibility testing of Cryptococcus neoformans.
    Del Poeta M; Barchiesi F; Morbiducci V; Arzeni D; Marinucci G; Ancarani F; Scalise G
    J Chemother; 1994 Jun; 6(3):173-6. PubMed ID: 7983499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response to antifungal therapy by human immunodeficiency virus-infected patients with disseminated Penicillium marneffei infections and in vitro susceptibilities of isolates from clinical specimens.
    Supparatpinyo K; Nelson KE; Merz WG; Breslin BJ; Cooper CR; Kamwan C; Sirisanthana T
    Antimicrob Agents Chemother; 1993 Nov; 37(11):2407-11. PubMed ID: 8285625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the Etest and microdilution method for antifungal susceptibility testing of Cryptococcus neoformans to four antifungal agents.
    Aller AI; Martín-Mazuelos E; Gutiérrez MJ; Bernal S; Chávez M; Recio FJ
    J Antimicrob Chemother; 2000 Dec; 46(6):997-1000. PubMed ID: 11102421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antifungal susceptibility of clinically isolated Candida albicans by broth microdilution method].
    Yamazumi T; Kuroda T; Ohata T; Obana Y; Furuta I
    Kansenshogaku Zasshi; 1998 Aug; 72(8):813-9. PubMed ID: 9780584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activity of D0870 compared with those of other azoles against fluconazole-resistant Candida spp.
    Wardle HM; Law D; Moore CB; Mason C; Denning DW
    Antimicrob Agents Chemother; 1995 Apr; 39(4):868-71. PubMed ID: 7785986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro antifungal activities of amphotericin B, 5-fluorocytosine, fluconazole and itraconazole against Cryptococcus neoformans isolated from cerebrospinal fluid and blood from patients in Serbia.
    Trpković A; Pekmezović M; Barać A; Crnčević Radović L; Arsić Arsenijević V
    J Mycol Med; 2012 Sep; 22(3):243-8. PubMed ID: 23518082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of media on growth rate and susceptibility testing of Cryptococcus neoformans.
    St-Germain G; Dion C
    Mycoses; 1996; 39(5-6):201-6. PubMed ID: 8909030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antifungal activity of a new triazole, D0870, compared with four other antifungal agents tested against clinical isolates of Candida and Torulopsis glabrata.
    Pfaller MA; Bale MJ; Buschelman B; Rhomberg P
    Diagn Microbiol Infect Dis; 1994 Jun; 19(2):75-80. PubMed ID: 7805359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In-vitro activity of the new triazole D0870 compared with amphotericin B and itraconazole against Aspergillus spp.
    Moore CB; Law D; Denning DW
    J Antimicrob Chemother; 1993 Dec; 32(6):831-6. PubMed ID: 8144422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro antifungal-drug susceptibilities of mycelial and yeast forms of Penicillium marneffei isolates in Cambodia.
    Sar B; Boy S; Keo C; Ngeth CC; Prak N; Vann M; Monchy D; Sarthou JL
    J Clin Microbiol; 2006 Nov; 44(11):4208-10. PubMed ID: 16971649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antimicrobial drug therapy and microbial sensitivity tests--antifungal agents and microbial sensitivity tests].
    Yamaguchi H
    Rinsho Byori; 1997 Jul; Suppl 105():182-90. PubMed ID: 9379538
    [No Abstract]   [Full Text] [Related]  

  • 15. In vitro susceptibility of 245 yeast isolates to amphotericin B, 5-fluorocytosine, ketoconazole, fluconazole and itraconazole.
    Martín E; Parras P; Lozano MC
    Chemotherapy; 1992; 38(5):335-9. PubMed ID: 1337508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multi-centre evaluation of the Etest method for antifungal drug susceptibility testing of Candida spp. and Cryptococcus neoformans. BSAC Working Party on Antifungal Chemotherapy.
    Warnock DW; Johnson EM; Rogers TR
    J Antimicrob Chemother; 1998 Sep; 42(3):321-31. PubMed ID: 9786472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro sensitivity of Penicillium marneffei and Pythium insidiosum to various antifungal agents.
    Sekhon AS; Padhye AA; Garg AK
    Eur J Epidemiol; 1992 May; 8(3):427-32. PubMed ID: 1397206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of pH and buffer system on the in-vitro activity of five antifungals against yeasts.
    Gadea I; Cuenca M; Gegúndez MI; Zapardiel J; Valero ML; Soriano F
    J Antimicrob Chemother; 1997 Apr; 39(4):453-9. PubMed ID: 9145817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modification of the fluorescein diacetate assay for screening of antifungal agents against Candida albicans: comparison with the NCCLS methods.
    Brouwer N; Kohen J; Jamie J; Vemulpad S
    J Microbiol Methods; 2006 Aug; 66(2):234-41. PubMed ID: 16406566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of pH on the in vitro activities of amphotericin B, itraconazole, and flucytosine against Aspergillus isolates.
    Te Dorsthorst DT; Mouton JW; van den Beukel CJ; van der Lee HA; Meis JF; Verweij PE
    Antimicrob Agents Chemother; 2004 Aug; 48(8):3147-50. PubMed ID: 15273136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.